Is 4D Molecular Therapeutics Inc (NASDAQ: FDMT) No Longer A Good Investment?

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.

Stocks Info

FDMT belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of 4D Molecular Therapeutics Inc is $193.54M. A total of 0.64 million shares were traded on the day, compared to an average of 926.19K shares.

In the most recent transaction, Bizily Scott sold 500 shares of FDMT for 16.33 per share on Sep 16 ’24. After the transaction, the Chief Legal Officer now owns 6,781 company shares. In a previous transaction on Aug 19 ’24, Bizily Scott sold 500 shares at 15.00 per share. FDMT shares that Chief Legal Officer owns now total 6,781.

Among the insiders who sold shares, Bizily Scott disposed of 1,750 shares on Jul 16 ’24 at a per-share price of $27.11. This resulted in the Chief Legal Officer holding 6,781 shares of FDMT after the transaction. In another insider transaction, Bizily Scott sold 1,996 shares at $25.00 per share on Jul 11 ’24. Company shares held by the Chief Legal Officer now total 6,781.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, FDMT has a high of $36.25 and a low of $3.73.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. FDMT’s latest balance sheet shows that the firm has $247.78M in Cash & Short Term Investments as of fiscal 2021. There were $16.45M in debt and $16.34M in liabilities at the time. Its Book Value Per Share was $11.15, while its Total Shareholder’s Equity was $319.11M.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for FDMT is Buy with a score of 4.27.

Most Popular

Related Posts